Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Sales (2016 - 2025)

Ptc Therapeutics has reported Return on Sales over the past 14 years, most recently at 8.34% for Q4 2025.

  • Quarterly results put Return on Sales at 8.34% for Q4 2025, down 791.0% from a year ago — trailing twelve months through Dec 2025 was 0.32% (up 31.0% YoY), and the annual figure for FY2025 was 0.32%, up 16.0%.
  • Return on Sales for Q4 2025 was 8.34% at Ptc Therapeutics, down from 0.08% in the prior quarter.
  • Over the last five years, Return on Sales for PTCT hit a ceiling of 2.08% in Q4 2021 and a floor of 8.34% in Q4 2025.
  • Median Return on Sales over the past 5 years was 0.59% (2024), compared with a mean of 0.68%.
  • Biggest five-year swings in Return on Sales: surged 326bps in 2023 and later crashed -791bps in 2025.
  • Ptc Therapeutics' Return on Sales stood at 2.08% in 2021, then tumbled by -158bps to 1.22% in 2022, then surged by 268bps to 2.05% in 2023, then crashed by -121bps to 0.43% in 2024, then tumbled by -1822bps to 8.34% in 2025.
  • The last three reported values for Return on Sales were 8.34% (Q4 2025), 0.08% (Q3 2025), and 0.36% (Q2 2025) per Business Quant data.